Dasatinib (Brand examples may vary) – Patient-Friendly Guide (UK)

Dasatinib is a medicine used to treat certain cancers of the blood, most notably some types of leukaemia. It works by blocking specific signals inside cancer cells that help them grow and survive. This guide explains how dasatinib works, how it is taken, what to expect, and how to stay safe.

Please note: individual treatment plans differ. Always follow the advice given by your healthcare team and read the patient information leaflet supplied with your medicine.

1) Basic product information

Medicine name: Dasatinib
Medicine type: Targeted anti-cancer medicine (a tyrosine kinase inhibitor)
How it may be supplied: Tablets or tablets in different strengths (exact packaging varies)
Common indications in adults: Certain Philadelphia chromosome-positive (Ph+) leukaemias
Common conditions treated: Chronic myeloid leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL), depending on your specific situation
UK availability: Widely used in specialist oncology/haematology settings; availability may depend on local formularies and hospital pathways

Dasatinib is often prescribed in line with national guidance and specialist protocols. In the UK, it is typically supplied through hospital pharmacies and/or contracted supply routes, and availability can also be affected by stock and strength.

2) How dasatinib works (mechanism of action)

Cancer cells can rely on abnormal signalling proteins to keep growing. In many cases of Ph+ leukaemia, a genetic change creates a fusion protein that is “always switched on”. One key example is BCR-ABL.

Dasatinib blocks several tyrosine kinases, including BCR-ABL. By inhibiting these signals, dasatinib can:

Reduce uncontrolled growth of leukaemia cells
Induce cell cycle arrest and cell death
Help achieve and maintain disease control in appropriate patients
Work even when cells have certain resistance patterns (depending on the clinical scenario)

Because dasatinib affects signalling pathways in cells throughout the body, it can also cause side effects such as effects on the blood, the heart/lungs (in some people), and digestive symptoms.

3) Pharmacokinetics (how your body handles dasatinib)

Pharmacokinetics (PK) describes what happens after you take a medicine: absorption, how it’s distributed, how it’s broken down, and how it’s removed.

Absorption and onset

Dasatinib is taken by mouth and is absorbed into the bloodstream.
Levels in the blood may rise over hours after a dose.
Peak concentrations are reached some time after taking it (the exact timing can vary by person and formulation).

Distribution and metabolism

Dasatinib is highly protein-bound, which helps determine where it travels in the body.
It is primarily metabolised by liver enzymes (notably CYP3A4), so medicines that affect these enzymes can change dasatinib levels.

Elimination

Dasatinib and its metabolites are eliminated mainly through faeces (and also some through urine), after hepatic processing.
The body may take days to fully clear changes in drug levels after dose adjustments or interruptions.

Because metabolism depends on liver enzymes, your healthcare team may check: liver function tests, full blood counts, and sometimes heart/lung assessments.

4) Typical use and indications

Dasatinib is used to treat specific subtypes of leukaemia, particularly those linked to the Philadelphia chromosome (Ph+).

Common indications (UK clinical use)

Chronic myeloid leukaemia (CML) in adults: typically including cases resistant or intolerant to prior therapy, and/or in specific phases depending on clinical details.
Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL): in adults (and sometimes in adolescents/paediatric patients) depending on specialist decision and regimen.
Other specialist situations may apply based on molecular testing, disease stage (e.g., chronic, accelerated, blast phases), prior treatments, and tolerance.

Your oncology team will specify your exact indication and target response, using blood tests and specialised monitoring.

5) How and when to take dasatinib (timing)

Dasatinib is commonly taken once daily or sometimes twice daily depending on the strength and treatment plan. Your prescription instructions (or treatment plan documents) will confirm the exact schedule.

Practical timing tips

Take it at the same time each day to help maintain consistent blood levels.
If you miss a dose, follow the advice in your medicine leaflet or your healthcare team’s instructions.
If vomiting occurs soon after taking a dose, contact your healthcare team for specific advice. Do not automatically take an extra dose unless instructed.

Consistency matters

Dasatinib is sensitive to food effects (see below). Consistency with regard to meals helps prevent unexpected changes in absorption.

6) Food interactions and what to eat/avoid

Food can affect how much dasatinib your body absorbs. This can influence both effectiveness and side effects.

General guidance

Many patients are advised to take dasatinib without food (for example, at least some time before or after a meal). The exact “time gap” may depend on the formulation and local guidance.
If your leaflet or clinician instructs a particular schedule (e.g., take on an empty stomach), follow that schedule strictly.

If you are unsure, check your patient information leaflet or ask your pharmacist for advice tailored to your dosing instructions.

Grapefruit and similar products

Citrus products like grapefruit and their juices can affect drug metabolism in some people. To reduce risk, it’s often recommended to avoid grapefruit unless your healthcare team confirms it is safe for you.

7) Alcohol and medicine interactions

Alcohol

There is no single “universal” safe amount of alcohol with dasatinib for everyone. Alcohol can:

Increase stress on the liver, especially if you already have liver-related side effects or abnormal liver tests
Worsen fatigue, nausea, or dizziness

Consider keeping alcohol to a minimum and discussing your typical intake with your specialist team.

Important medicine interactions

Dasatinib is metabolised via CYP3A4, so medicines that inhibit or induce this enzyme can change dasatinib exposure. This may require dose adjustment or avoiding the combination.

Examples of medicines to discuss with your pharmacist/doctor

Strong CYP3A4 inhibitors (may increase dasatinib levels): some antifungals (e.g., certain azoles), some macrolide antibiotics, and some antivirals
Strong CYP3A4 inducers (may reduce dasatinib levels): some anti-epileptics (depending on the drug), and rifamycin antibiotics
Acid-reducing medicines: proton pump inhibitors (PPIs) and some medicines that reduce stomach acid can affect absorption. Your clinician may advise avoiding certain agents or using alternatives
Anticoagulants/antiplatelets: because blood counts can drop and clotting risk can change, your team may monitor more closely
Other anti-cancer or investigational agents: combination regimens require careful monitoring

Always provide your pharmacist with a complete list of: prescription medicines, over-the-counter products (including painkillers and cold/flu remedies), herbal supplements, and vitamins.

8) Dosing: what patients should know

The dose of dasatinib depends on the indication, phase of disease, prior treatments, your blood counts, tolerance, and other medicines you may take.

Starting dose and adjustments

Commonly, dosing is once daily, but some regimens may be twice daily.
Your specialist may adjust the dose based on:
- Full blood count results (neutrophils, platelets, haemoglobin)
- Side effects such as fluid retention, infections, or rash
- Liver function tests
- Heart/lung symptoms (in certain risk scenarios)
Dose interruptions may be used to help the body recover from side effects.

Strengths

Dasatinib is supplied in different tablet strengths. Do not substitute tablets of another strength unless your clinician instructs it.

How to take the tablets

Swallow tablets whole with water, unless your leaflet instructs otherwise.
Do not crush or split unless the product leaflet states it is safe for that specific formulation.
Store at room temperature, protected from moisture, and keep out of reach of children.

If you have difficulty swallowing tablets, discuss options with your pharmacist. Do not improvise without guidance.

9) Safety profile and side effects

Like all medicines, dasatinib can cause side effects. Many are manageable, but some require urgent medical attention. Your healthcare team will monitor you regularly, including blood tests and symptom checks.

Common side effects

Low blood counts (may lead to infection, tiredness, or bruising/bleeding)
Fatigue
Rash or skin dryness
Nausea, diarrhoea, constipation, or abdominal discomfort
Headache
Fluid retention (swelling of ankles/legs in some people)
Muscle or joint pain

Serious side effects (seek urgent help)

Contact your healthcare team promptly or seek urgent medical advice if you experience:

Breathlessness, persistent cough, or chest tightness (possible lung-related effects)
Severe or persistent swelling or rapid weight gain (possible fluid-related complications)
Unusual bruising or bleeding, or signs of severe infection (fever, chills, sore throat)
Signs of liver problems: yellowing of the skin/eyes, dark urine, severe right-sided abdominal pain
Severe dizziness, fainting, or palpitations

Monitoring typically includes

Full blood counts regularly (to monitor neutrophils and platelets)
Liver function tests
Assessment of fluid retention and shortness of breath
Any specialist investigations requested by your oncology team

Pregnancy and breastfeeding

If you are pregnant or trying to conceive, discuss this urgently with your specialist team. Many anti-cancer medicines can harm an unborn baby. Contraception advice is usually provided for both women and men taking targeted cancer treatments.

Breastfeeding is generally not recommended during treatment with anti-cancer medicines. Ask your healthcare team for specific advice.

10) Practical use tips (day-to-day)

Reduce missed doses

Use alarms or phone reminders for your dosing time.
Keep a medication diary (especially during dose changes or interruptions).
If you travel, plan your supply and keep tablets in their original packaging.

Manage nausea and digestive symptoms

Stay hydrated and eat small, frequent meals if nausea occurs.
Follow the food timing advice for dasatinib to avoid absorption issues.
Report persistent symptoms to your clinician—anti-nausea medication may be appropriate.

Protect yourself from infection

Because blood counts can be lower, try to avoid close contact with people who are unwell.
Seek advice promptly if you develop fever or signs of infection.
Follow any neutropenia/infection precautions your team provides.

Know when to call your team

New or worsening breathlessness
Unexplained bleeding or severe bruising
Significant swelling, weight gain, or severe headaches
Symptoms of liver problems
Any allergic-type reaction (e.g., widespread rash with swelling or breathing difficulty)

11) Alternative options (discuss with your specialist)

Treatment choices depend on your specific disease characteristics, prior therapies, and how well you tolerate each option. If dasatinib isn’t suitable, your specialist may consider other targeted medicines.

Common alternative targeted therapies for Ph+ leukaemia

Imatinib (a well-known first-line targeted option in many settings)
Nilotinib
Bosutinib
Ponatinib (in selected circumstances)

Your healthcare team will determine the best option based on response, resistance, mutation profile, and safety considerations.

12) UK market and legal context (what this means for you)

In the United Kingdom, dasatinib is an established medicine used in specialist oncology and haematology services. Its use is governed by clinical guidance, national health systems pathways, and medicines regulation.

The UK medicines landscape includes:

Regulatory oversight through the Medicines and Healthcare products Regulatory Agency (MHRA)
Clinical guidance produced by bodies such as NICE and specialist societies (where applicable to each setting)
Specialist prescribing arrangements because complex cancer regimens require monitoring and coordination across specialist teams
Supply considerations including batch availability, stock movement, and handling requirements for cold-chain products (if any), though dasatinib tablets typically do not require refrigeration

If you are purchasing via an online pharmacy, quality, sourcing, and compliance with UK medicine supply regulations are essential. Only buy medicines from reputable, authorised channels.

13) Recent guidance and monitoring updates (UK context)

Over time, cancer medicine management evolves as new evidence emerges. In recent years, key themes in guidance have included:

More structured monitoring of blood counts and early recognition of side effects
Closer attention to heart and lung symptoms, particularly breathlessness and fluid retention
More emphasis on drug–drug interactions, especially via liver enzyme pathways and stomach-acid-related medicines
Individualised treatment plans based on response and tolerability rather than a single “standard” approach for everyone

Your specialist team will follow the most current protocols available in the UK. If you have questions about your monitoring schedule, ask your oncologist or pharmacist.

14) Delivery and availability (UK online pharmacy)

Availability can vary by tablet strength and market demand. When you order online, typical expectations include:

Stock checks before dispatch
Estimated delivery windows based on location within the UK
Discrete packaging for privacy (if offered by the pharmacy)
Handling and storage instructions included with your order

If a particular strength is temporarily out of stock, the pharmacy may offer alternatives such as:

Ordering from an alternative supplier route
Delaying dispatch until stock is confirmed
Confirming a different strength only if this matches your treatment plan

If you need your medicine urgently, contact the online pharmacy’s support team for real-time stock information and dispatch timing.

15) Summary table – key points at a glance

Topic	What to remember
What it is	Targeted cancer medicine (tyrosine kinase inhibitor) for Ph+ leukaemias
How it works	Blocks BCR-ABL and other kinases to disrupt cancer cell signalling
How to take	Usually once daily; follow your exact schedule and tablet strength instructions
Food	Food can affect absorption; often taken without food—follow leaflet guidance
Interactions	Many interactions via liver enzymes (CYP3A4) and stomach acid medicines—check before starting anything new
Safety monitoring	Regular blood tests and symptom checks; report breathlessness, swelling, fever, or bleeding urgently
Alcohol	Keep alcohol minimal; discuss with your team, especially if liver tests are abnormal
When to seek help	Breathing problems, severe swelling, signs of severe infection, or bleeding/major bruising

16) FAQ

How quickly does dasatinib start working?

Responses vary widely. Some people may see early improvements in symptoms or blood markers, while deeper responses can take weeks to months. Your specialist will monitor response using blood tests and molecular assessments.

Can I take dasatinib with food?

Food can change how much dasatinib your body absorbs. Many regimens advise taking it on an empty stomach or with specific time gaps from meals. Follow the instructions provided with your medicine and confirm with your pharmacist if unsure.

What should I do if I miss a dose?

Advice depends on how close it is to your next dose. Check the patient leaflet or ask your pharmacist for personalised guidance. Avoid doubling up without instructions.

Are there foods or drinks I should avoid?

Grapefruit (and possibly other grapefruit-containing products) may interact with medicines metabolised by CYP enzymes. Also, follow the meal timing instructions on your regimen. If you want to change your diet substantially, ask your pharmacist.

Does dasatinib interact with heartburn or acid-suppressing medicines?

Some medicines that reduce stomach acid can affect dasatinib absorption. Do not start or stop acid-reducing therapies without discussing with your healthcare team. Your clinician may recommend an alternative plan.

Is it safe to drink alcohol while taking dasatinib?

Alcohol may worsen fatigue or nausea and could affect the liver. A small amount may be acceptable for some people, but discuss your situation with your specialist team—especially if liver tests are abnormal or you have ongoing side effects.

What side effects are most important to watch for?

Report promptly: breathlessness or persistent cough, significant swelling, fever or signs of infection, unusual bleeding/bruising, and symptoms suggesting liver issues (such as yellowing of the skin/eyes).

Will I need regular blood tests?

Yes. Regular full blood counts are typical to monitor for low white blood cells and platelets, along with liver function tests. Monitoring frequency depends on your phase of treatment and how you are responding.

What can I do about fatigue?

Fatigue is common. Aim for gentle activity where possible, prioritise rest, hydrate, and discuss severity with your team. If fatigue is severe or worsening, it may relate to blood count changes or other side effects—your clinician can assess.

Are there alternatives if I cannot tolerate dasatinib?

Other targeted medicines may be suitable depending on your disease and prior treatment history. Your oncologist will balance effectiveness and side-effect profile when selecting alternatives.

How should I store dasatinib tablets?

Store according to the leaflet (typically at room temperature, in a dry place, and in original packaging). Keep out of sight and reach of children.

Important note

This information is designed to help you understand dasatinib in general terms and is not a substitute for personalised medical advice. If you have concerns about side effects, interactions, or your dosing routine, contact your healthcare team or pharmacist.

Additional information

Dosage: No selection	50mg
Package: No selection	1 bottle, 2 bottle, 3 bottle

Dasatinib